Trials / Completed
CompletedNCT00946608
To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets
Comparative, Randomized, Single-Dose, 3-way Crossover Bioavailability Study of Sandoz Inc. and Schering (Claritin) 10 mg Loratadine Tablets In Healthy Adult Male Volunteers Under Fed and Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability study of Loratadine 10 mg tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Loratadine 10 mg Tablets Under Fasting Conditions (Sandoz, Inc.) | |
| DRUG | Loratadine 10 mg Tablets Under Fed Conditions (Sandoz, Inc.) | |
| DRUG | Claritin (Loratadine) 10 mg Tablets Under Fed Conditions (Schering) |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946608. Inclusion in this directory is not an endorsement.